Faris Alrumaihi

49PUBLICATIONS
95CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersChemotherapyLiquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (49)

|Jun 26, 2026
Screening of Natural Product-Derived USP7 Inhibitors for Cancer Therapy via Integrated Machine Learning and Molecular Simulations.

|Jan 30, 2026
Cancer Vaccines: Molecular Mechanisms, Clinical Progress, and Combination Immunotherapies with a Focus on Hepatocellular Carcinoma.

Faris Alrumaihi, Reem A Alromaihi, Vikalp Kumar

|Sep 27, 2025
Ferroptosis-Linked Six-Gene Panel Enables Machine Learning-Assisted Diagnosis and Therapeutic Guidance in Lung Adenocarcinoma.

Faris Alrumaihi

|Jul 29, 2025
The Role of Plant-Derived Natural Products as a Regulator of the Tyrosine Kinase Pathway in the Management of Lung Cancer.

Faris Alrumaihi, Arshad Husain Rahmani, Sitrarasu Vijaya Prabhu

|Jul 12, 2025
Role of Liquid Biopsy for Early Detection, Prognosis, and Therapeutic Monitoring of Hepatocellular Carcinoma.

Faris Alrumaihi

|Apr 26, 2025
Lipid-Based Nanoformulations of [6]-Gingerol for the Chemoprevention of Benzo[a] Pyrene-Induced Lung Carcinogenesis: Preclinical Evidence.

Faris Alrumaihi, Ali Yousif Babiker, Arif Khan

Pageof 9

Frequent Collaborators

32 joint publications

Khaled S Allemailem

29 joint publications

Ahmed A Almatroudi

12 joint publications

Arif Khan

11 joint publications

Masood Alam Khan